Our gola is to have ALL CGM devices on our platform. Broadly speaking, health systems have interest in supporting data collection from devices their patients are already using, especially while supporting chronic conditions such as diabetes. Long-term, Locus will offer normalized views and consistent integration experiences for many more devices. Ideally, with large enough data sets, we will be able to leverage innovations in AI Healthcare Co-pilots to support clinical staff in minimizing delays, increasing efficiency, and improving remote patient monitoring outcomes. In the longer term, we intend to be a key partner in all of our health systems’ population health engines. 

Strategically, Locus is focused on: 

(1) helping our customer health systems leverage the critical investment they’ve made in existing technology platforms like the EHR, creating impact for key patient populations where remote care management can most effectively drive outcomes and return on investment. 

(2) meeting our health system care teams where they are, recognizing the reality of patient monitoring and navigation needs vs available provider resources and ensuring that our platform’s ability to collect, synthesize, and transmit key population and patient-specific data supports the efficiency of their teams’ workflows and innovative approaches to coordinated care. 

(3) providing a single-platform “middleware plus” approach to integration, allowing health system teams to choose their preferred remote devices and seamlessly integrate with other relevant patient information via Locus to the EHR 

(4) helping our health system customers view and establish Remote Care Management (both RPM and Navigation) as a strategic capability, supporting both enhanced quality outcomes and becoming a positive-ROI profit center (via enhanced reimbursement revenue and/or lower preventable costs). 

Glooko improves health outcomes of people with chronic conditions through its personalized, intelligent, connected care platform. Our proven technologies make lives better by revolutionizing the connection between patients and providers, driving patient engagement and adherence via digital therapeutics, and accelerating the speed of clinical trials.